Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon and Exercise in Type 1 Diabetes
NCT02882737Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Sep 2016
- Primary completion
- Jul 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of glucagon in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Peak plasma glucose achieved within 2 hours. Started Sep 2016; status: completed.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02882737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02882737.